Clinical Trial Vanguard

Clinical Trial Vanguard

Clinical Trial Vanguard is a US-based media platform founded by Paul Ivsin that provides news, analysis, podcasts, videos, and expert interviews focused on the clinical trials industry. The platform emphasizes patient centricity and diversity in clinical research, and also organizes summits and conferences related to clinical trials.

Claims from Clinical Trial Vanguard

Clinical Trial Vanguard
Clinical Trial Vanguard"The first FDA approval of an AI-discovered drug, projected for sometime in 2026 or 2027, will be treated as a validation event for the entire sector."Aug 27, 2026
© 2026 Improve the News Foundation. All rights reserved.Version 8.0.0

© 2026 Improve the News Foundation.

All rights reserved.

Version 8.0.0